Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Horizon Therapeutics"
Count: 34
Selected: 0
NCT IDTitle
NCT04948099A Study of Single and Multiple Ascending Doses of VIB1116 in Rheumatic Diseases
NCT04129164A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome
NCT04925934Study of VIB7734 for the Treatment of Moderate to Severely Active SLE
NCT04046549A Study to Evaluate the Safety and Efficacy of Dual Costimulation Blockade With VIB4920 and Belatacept for Prophylaxis of Allograft Rejection in Adults Receiving a Kidney Transplant
NCT04524273Myasthenia Gravis Inebilizumab Trial
NCT04540497A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease
NCT03335488Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders
NCT01948427Observational Study That Will Collect Information on Patients With Urea Cycle Disorders (UCDs)
NCT05032066A Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis
NCT05549258Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
NCT05540665Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis
NCT04781543A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis
NCT04087720Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant
NCT05430854Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study
NCT04762498A Phase 4, Open-label Study of KRYSTEXXA® (Pegloticase) Co-administered With Methotrexate (MTX) in Patients With Uncontrolled Gout (FORWARD OL)
NCT03994731Study of KRYSTEXXA® (Pegloticase) Plus Methotrexate in Participants With Uncontrolled Gout
NCT05368103Study of DAXDILIMAB for the Treatment of Moderate-to-Severe Alopecia Areata
NCT04511702Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate
NCT02246218A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle Disorders
NCT04772313Pegloticase and Methotrexate Co-administered in Patients With Uncontrolled Gout Who Have Previously Failed Pegloticase Monotherapy
NCT03635957Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout
NCT01257737To Evaluate the Safety of Long-term Use of HPN-100 in the Management of Urea Cycle Disorders (UCDs)
NCT05002998TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study
NCT04583735A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease
NCT04478994A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
NCT04174677Safety and Tolerability of Inebilizumab, VIB4920, or the Combination in Highly Sensitized Candidates Awaiting Kidney Transplantation From a Deceased Donor
NCT04163991A Study to Evaluate the Safety and Efficacy of VIB4920 in Participants With Rheumatoid Arthritis
NCT04526912Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection
NCT03817424A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis
NCT02780388A Phase 1b Study of MEDI4920 in Participants With Adult-onset Rheumatoid Arthritis
NCT03621605A Phase1 Study of VIB9600
NCT02780674A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases
NCT02464501The OPC for Optimal Delivery of Paclitaxel for the Prevention of Endovascular Restenosis - Above and Below the Knee
NCT02395744The COPPER-B Trial